Y. Ozawa et al,. Chemical composition of soybean oil extracted from hypocotyl-enriched soybean raw material and its cholesterol lowering effects in rats. J. Oleo Sci. 2001; 50: 217-223.
T. Schryver, Increasing health benefits using soy germ Cer. Foods World 2002; 47: 185-188.
K. Setchell, Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin Nutr. 1998; 68: 1333S.
Consensus Opinion Role of Isoflavones in menopausal health. J. of NAMS, 2000, 7 (4): 215-19.
Nagata c et al. Soy and other dietary factors in relation with premenstrual symptoms. BJOG, 2004, 111 (6), 594-6.
R.A. Moreau et al., Phytosterols, phytostanols and their conjugated in foods: structural diversity, quantitative analysis and healthpromoting uses. Progr. Lipid Res. 2002; 41: 457-500.
A. Faraj et al., Soybean isoflavones: Effects of processing and health benefits. Food Rev. Int. 2004; 20: 51-75.
E.B Schmidt, n-3 Fatty acids and the risk of coronary heart disease. Danish Med. Bull. 1997; 44 (1): 1-22.
D.S. Kelley, Modulation of human immune and inflammatory responses by dietary fatty acids. Nutrition 2001; 17: 669-673.
R. J. Hamilton et al., Chemistry of Free Radicals in Lipids. Food Chem. 1997; 60: 193-199.
Consensus Opinion Role of isoflavones in menopausal health. Menopause. J. of NAMS 2000; 7 (4): 215-219.
P.E. Nahas et al. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas 2004; 48 (4): 372-380.
M.L. Ricketts et al., Molecular mechanism of activation of the soy isoflavones includes activation of promiscuos nuclear receptors. A review. J. Nutr. Biochem. 2005; 16 (6): 321-330.
Food and Drug administration. FDA Dockets Management Branch, Rockville, MD, 1999. 21 CFR part 101. FDA Docket No. 98P-0683: 57-700.
A.O. Omoni, R.E. Aluko, Soybean foods and their benefits: Potential mechanisms of action. Nutr. Rev. 2005; 63(8): 272-283.
Z.C. Dang, C. Lowik, Dose-dependent effects of phytoestrogens on bone. Trends in Endocrinol. and Metabol. 2005, 16(5): 207-213.
M.L. Ricketts, D.D. Moore et al, Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear Receptors. J. Nutr. Biochem. 2005, 16(6): 321-330.
H. Wiseman, The therapeutic potential of phytoestrogens. Exp. Opin. Invest. Drugs 2000; 9: 1829.
T.B. Clarkson et al., Estrogenic Soybean Isoflavones and Chronic Disease: Risks and Benefits. Trends Endocr. Metab. 1995; 6: 11-16.
W.H. Ling et al., Dietary Phytosterols: a review of metabolism, benefits and side-effects. Life Sciences 1995; 57: 195-206.
P. Nestel, Isoflavones their effects on cardiovascular risk and functions. Curr. Op. Lip. 2003; 14: 3-8.
L.I. Christiansen, Cholesterol-lowering effect of spreads enriched with microcrystal line plant sterols in hypercholesterolemic subjects. Eur. J. Nutr. 2001; 40: 66-73.
M. Gatchalian-Yee et al., Undigested fraction of soybean protein and cholesterol metabolism. Nutrition 1997; 13: 633-639.
G. Cravotto et al., Soybean-germ oil inhibits oxidosqualene cyclase in 3T3 fibroblasts. Eur. J. Lipid Sci. & Tech. 2005, 107 (10): 701-705.
Y. Kawakami, et al., Regulative actions of dietary soy isoflavone on biological antioxidative system and lipid metabolism in rats. J. Agr. Food Chem. 2004; 52: 1764-1768.
